Literature DB >> 3473473

Identification of a mammalian glutaminyl cyclase converting glutaminyl into pyroglutamyl peptides.

W H Fischer, J Spiess.   

Abstract

Extracts from bovine pituitary were found to contain an activity catalyzing the conversion of glutaminyl peptides such as [Gln1]gonadotropin-releasing hormone, [Gln1, Gly4]thyrotropin-releasing hormone (H-Gln-His-Pro-Gly-OH), and H-Gln-Tyr-Ala-OH to the respective pyroglutamyl peptides. The TRH precursor fragment H-Lys-Arg-Gln-His-Pro-Gly-Lys-Arg-OH and the D-glutaminyl stereoisomer of H-Gln-Tyr-Ala-OH did not react under the same conditions. The conversion products were identified by Edman degradation, amino acid analysis, and reversed-phase HPLC. That this activity was exhibited by an enzyme, glutaminyl cyclase, was concluded from the protein character of the activity (revealed by its abolition with trypsin and heat), the Michaelis-Menten relationship between substrate concentration and conversion rate, and the substrate specificity. It was determined that glutaminyl cyclase had a molecular weight of 43,000-50,000, a pH optimum at pH 8, and Km and Vmax values in the range of 60-130 microM and 390-690 pmol/microgram per hr, respectively. Glutaminyl cyclase was not observed to require ATP and could be inhibited with 1.0 M ammonium chloride, which increased the Km and decreased the Vmax value. The subcellular distribution of glutaminyl cyclase corresponded to the one of peptidylglycine alpha-amidating monooxygenase believed to catalyze C-terminal amidations during posttranslational precursor processing. It was also observed that the formation of pyroglutamyl from glutaminyl peptides occurred nonenzymatically; however, the enzymatic reaction carried out with crude extract was found to be approximately 70 times faster than the nonenzymatic reaction enhanced by phosphate. It is speculated that glutaminyl cyclase may participate in the posttranslational processing of hormonal precursors to pyroglutamyl peptides.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3473473      PMCID: PMC304928          DOI: 10.1073/pnas.84.11.3628

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

1.  Serum 5-nucleotidase.

Authors:  T F DIXON; M PURDOM
Journal:  J Clin Pathol       Date:  1954-11       Impact factor: 3.411

2.  Thyrotropin-releasing hormone precursor: characterization in rat brain.

Authors:  R M Lechan; P Wu; I M Jackson; H Wolf; S Cooperman; G Mandel; R H Goodman
Journal:  Science       Date:  1986-01-10       Impact factor: 47.728

3.  The sequence of sheep kappa-casein: primary structure of para-kappa A-casein.

Authors:  J Jollès; F Schoentgen; J Hermann; C Alais; P Jollés
Journal:  Eur J Biochem       Date:  1974-07-01

4.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

Authors:  W Vale; J Spiess; C Rivier; J Rivier
Journal:  Science       Date:  1981-09-18       Impact factor: 47.728

5.  Mechanism of C-terminal amide formation by pituitary enzymes.

Authors:  A F Bradbury; M D Finnie; D G Smyth
Journal:  Nature       Date:  1982-08-12       Impact factor: 49.962

6.  Identification in pituitary tissue of a peptide alpha-amidation activity that acts on glycine-extended peptides and requires molecular oxygen, copper, and ascorbic acid.

Authors:  B A Eipper; R E Mains; C C Glembotski
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

7.  Characterization of cDNA for precursor of human luteinizing hormone releasing hormone.

Authors:  P H Seeburg; J P Adelman
Journal:  Nature       Date:  1984 Oct 18-24       Impact factor: 49.962

8.  Translation of melittin messenger RNA in vitro yields a product terminating with glutaminylglycine rather than with glutaminamide.

Authors:  G Suchanek; G Kreil
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

9.  Isolation and sequence analysis of a somatostatin-like polypeptide from ovine hypothalamus.

Authors:  J Spiess; J Villarreal; W Vale
Journal:  Biochemistry       Date:  1981-03-31       Impact factor: 3.162

10.  Biosynthesis of thyrotropin releasing hormone in the skin of Xenopus laevis: partial sequence of the precursor deduced from cloned cDNA.

Authors:  K Richter; E Kawashima; R Egger; G Kreil
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

View more
  50 in total

1.  The enterins: a novel family of neuropeptides isolated from the enteric nervous system and CNS of Aplysia.

Authors:  Y Furukawa; K Nakamaru; H Wakayama; Y Fujisawa; H Minakata; S Ohta; F Morishita; O Matsushima; L Li; E Romanova; J V Sweedler; J H Park; A Romero; E C Cropper; N C Dembrow; J Jing; K R Weiss; F S Vilim
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

2.  PYROGLUTAMATE FORMATION AT THE N-TERMINI OF ABRI MOLECULES IN FAMILIAL BRITISH DEMENTIA IS NOT RESTRICTED TO THE CENTRAL NERVOUS SYSTEM.

Authors:  Yasushi Tomidokoro; Akira Tamaoka; Janice L Holton; Tammaryn Lashley; Blas Frangione; Tamas Revesz; Agueda Rostagno; Jorge Ghiso
Journal:  Hirosaki Igaku       Date:  2010-07-08

3.  Oxidative folding and N-terminal cyclization of onconase.

Authors:  Ervin Welker; Laura Hathaway; Guoqiang Xu; Mahesh Narayan; Lovy Pradeep; Hang-Cheol Shin; Harold A Scheraga
Journal:  Biochemistry       Date:  2007-04-18       Impact factor: 3.162

4.  Functional anthology of intrinsic disorder. 3. Ligands, post-translational modifications, and diseases associated with intrinsically disordered proteins.

Authors:  Hongbo Xie; Slobodan Vucetic; Lilia M Iakoucheva; Christopher J Oldfield; A Keith Dunker; Zoran Obradovic; Vladimir N Uversky
Journal:  J Proteome Res       Date:  2007-03-29       Impact factor: 4.466

5.  The association of common polymorphisms in the QPCT gene with bone mineral density in the Chinese population.

Authors:  Qing-Yang Huang; Annie W C Kung
Journal:  J Hum Genet       Date:  2007-08-09       Impact factor: 3.172

6.  Primary structure and functional expression of a glutaminyl cyclase.

Authors:  T Pohl; M Zimmer; K Mugele; J Spiess
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

7.  The structure of the human glutaminyl cyclase-SEN177 complex indicates routes for developing new potent inhibitors as possible agents for the treatment of neurological disorders.

Authors:  Cecilia Pozzi; Flavio Di Pisa; Manuela Benvenuti; Stefano Mangani
Journal:  J Biol Inorg Chem       Date:  2018-08-21       Impact factor: 3.358

8.  Novel peptides from adrenomedullary chromaffin vesicles.

Authors:  J Sigafoos; W G Chestnut; B M Merrill; L C Taylor; E J Diliberto; O H Viveros
Journal:  J Anat       Date:  1993-10       Impact factor: 2.610

9.  Glutaminyl cyclases as novel targets for the treatment of septic arthritis.

Authors:  Annelie Hellvard; Katarzyna Maresz; Stephan Schilling; Sigrid Graubner; Ulrich Heiser; Roland Jonsson; Holger Cynis; Hans-Ulrich Demuth; Jan Potempa; Piotr Mydel
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

10.  Neuropeptidomics of the supraoptic rat nucleus.

Authors:  Adriana Bora; Suresh P Annangudi; Larry J Millet; Stanislav S Rubakhin; Andrew J Forbes; Neil L Kelleher; Martha U Gillette; Jonathan V Sweedler
Journal:  J Proteome Res       Date:  2008-09-25       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.